UK backs human challenge studies of COVID-19 vaccines with $44 mln fund

The government said it would invest 33.6 million pounds ($43.5 million) in the studies in partnership with Imperial College London, laboratory and trial services company hVIVO and the Royal Free London NHS Foundation Trust.

If approved by regulators and the ethics committee, the studies would start in January with results expected by May 2021, the government said.